Prevalence of chronic kidney disease among the veteran population is estimated to be 34% higher than the general population. Panelists will discuss the unique experience of veterans living with kidney disease along with a general background on kidney disease and its two leading risk factors: high blood pressure and diabetes. The panelists hope to stimulate a thought-provoking discussion regarding the mental health burdens veterans face when confronted with diagnoses of chronic medical conditions such as kidney disease and diabetes. Additionally, solutions to facilitating mental health care will be explored.
See how hundreds of kidney patients, caregivers, friends, and other community members are coming together virtually to walk/run 37 miles to honor the 37 million Americans living with kidney disease.
lgAN is a type of autoimmune disease that starts in the gut and over time, causes damage to the kidneys. Although testing urine for protein can indicate lgA nephropathy (lgAN), a kidney biopsy is the only test that give doctors an accurate diagnosis. Panelists will start with an overview of lgA nephropathy, then discuss its various treatment approaches for managing lgAN, including proper eating, ACEs/ARBs and new and emerging medicines. The panelists will also highlight patient resources offered by the lgAN Foundation of America, including its patient registry.
This session is made possible thanks to the generous support from Calliditas Therapeutics.
Join Licensed Clinical Social Worker, Elle Lee, as she guides you through where to find the best accessible mental health resources for CKD from a kidney patient’s experience.
Hyperkalemia (high potassium) is a serious problem and often a complication of advanced kidney disease. Hyperkalemia is a higher-than-normal level of potassium in the blood. Although mild cases may not cause symptoms and may be easy to treat, severe cases of hyperkalemia that are left untreated can lead to abnormal heart rhythms or even death.
While hyperkalemia can be managed somewhat by eating low-potassium foods, there are important medicines available that effectively manage this condition. Our panelists will give an overview of hyperkalemia, discuss treatments, and highlight the various no-cost hyperkalemia management resources featured on AKF’s Kidney Kitchen® and our Beyond Bananas™ campaign.
This session is made possible thanks to the generous support from AstraZeneca.
Experiences living with chronic kidney disease (CKD) vary from person to person. While some receive a diagnosis at an earlier stage, many do not, resulting in a delayed diagnosis, kidney failure and a “crash” into needing dialysis. The panelists will be sharing their individual stories about how they navigated their kidney disease journey. They will cover experiences with dialysis, transplant, and making lifestyle changes to slow the progression of CKD. There are so many decisions along the journey and this session highlights multiple perspectives and shows how these decisions impact loved ones as well.
With all the changes in kidney disease testing over the years, it can be unclear which tests provide the most accurate diagnosis. In this session, the panelists will be providing an overview of the landscape of kidney disease testing from the past, present, and future. The panelists will review the most common tests used to date (UACR and eGFR) and discuss the issues associated with each. In addition, the panelists will highlight recent changes to the eGFR equation and will discuss the future of kidney disease testing (cystatin-C, biomarkers, etc.). The goal of this session will be to bring awareness to the changes in kidney disease testing to empower the public to advocate for the test that is best for them.
AKF works on behalf of the 37 million Americans living with and at risk for kidney disease. From prevention to life after a transplant, AKF supports people wherever they are in their fight against kidney disease.
Contact us at [email protected] if you have questions or need help registering.